Massachusetts Medical Society

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.8M in lobbying spend across 33 quarterly filings, Massachusetts Medical Society is a significant lobbying presence. Their lobbying covers 10 issue areas. Active from 2018 to 2025.

$1.8M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
10
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$290K
2019$320K
2020$220K
2021$180K
2022$190K
2023$180K
2024$160K
2025$220K

Issues Lobbied

Copyright/PatentImmigrationHealth IssuesAlcohol & Drug AbuseMedicare/MedicaidFirearmsPharmacyEducationInsuranceTOB

Lobbying Firms

Massachusetts Medical Society

Lobbyists

Alexandra CalcagnoAlexandria IcenhowerCasey Rojas

Government Agencies Targeted

These are the government entities that Massachusetts Medical Society disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)Drug Enforcement Administration (DEA)HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Homeland Security, Dept of (DHS)Centers For Disease Control & Prevention (CDC)Office of Science & Technology Policy (OSTP)Health Resources & Services Administration (HRSA)Labor, Dept of (DOL)Treasury, Dept ofVeterans Affairs, Dept of (VA)White House OfficeFood & Drug Administration (FDA)Natl Institutes of Health (NIH)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Immigration, Health Issues, Alcohol & Drug Abuse, Medicare/Medicaid and 5 more

S. 1701 - Fair Access to Science and Technology Act - changes to copyright protections for publications

HR 496, S. 128 - Bridge Act - Codifies DACA protections for three years.

Alexander-Murray Bill on Cost-Sharing Reduction Funding and Section 1332 Waivers

Bipartisan Budget Act of 2018

Community Health Investment, Modernization, and Excellence Act of 2017 (HR 3770, S. 1899

HR 1625 Consolidated Appropriations ACT of 2018

$4 billion in opioid treatment

$2.3 billion for mental health programs: Increased funding for SAMHSAs Community Mental Health Services Block Grant (MHBG

Bipartisan Budget Act of 2018

MACRA - Revisions to the Medicare Access and Chip Reauthorization Act

Changes to the Medicare Physician Fee Schedule

National Health Service Corps reauthorization

Repea

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Tech Lobbying
Industry overview and top spenders
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Sage Therapeutics
$4.8M total spend
Bluebird Bio, INC.
$3.5M total spend
Sun Life Financial (U.S.) Services Company INC.
$2.3M total spend
Braeburn INC Formerly Known as Braeburn Pharmaceuticals INC
$1.9M total spend
Community Catalyst, INC
$1.4M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.